查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
雙室注射器 (DCS) 灌裝機的全球市場 - 2022-2029
市場調查報告書
商品編碼
1140711

雙室注射器 (DCS) 灌裝機的全球市場 - 2022-2029

Global Dual Chamber Syringe (DCS) Filling Machine Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

雙室注射器 (DCS) 灌裝機市場規模預計將在 2021 年達到 3.267 億美元，在 2029 年達到 5.081 億美元，在預測期間（2022-2029 年）的複合年增長率為 7.9%，預計將在

雙室注射器（DCS）灌裝機是一種用於灌裝雙室注射器的設備。DCS 機器設計用於用液體或粉末藥物的組合填充兩室預填充注射器。這些機器主要用於工業藥房和醫院藥房。

市場動態

市場增長受到各種因素的推動，例如注射器製造商的投資增加以及新技術的進步和採用新技術的改進。

預計科技進步和投資增加將推動市場增長。

全球雙腔注射器灌裝機市場的增長主要受到灌裝機技術進步的推動。與傳統的雙腔注射器相比，新的雙腔技術的更多采用提高了產品的可靠性、易用性和性能。隔離器和限制進入屏障系統 (RABS) 的引入提供了無菌製造環境，有效地將人工與填充和完成過程分開。填充和塗飾製造領域的幾家領先設備製造商正在使用新的屏障隔離系統進行創新，這些集成式填充和塗飾機器可以執行填充和塗飾過程的所有階段。另一方面，用於灌裝和精整操作的傳統設備既昂貴又耗時，使整個過程複雜化並且容易受到污染。傳統的灌裝機不銹鋼系統需要額外的清潔和滅菌 (CIP/SIP)。另一方面，一次性系統通過消除複雜的滅菌步驟和簡化批次末拆卸和去污，顯著減少了轉換時間。例如，DARA Pharmaceutical Packaging 展示了一款兩室注射器灌裝機。由於這些因素，一些生物製藥公司正在其製藥生產設施中安裝這些機器。

此外，生物製藥行業的增長和預充注射器製造商的投資增加也有望在預測期內推動市場增長。例如，Nipro Corporation 在德國和日本的工廠投資 1400 萬美元，以擴大其預充式註射器的生產能力。該公司還在開髮用於治療前列腺癌和乳腺癌患者的雙腔預充式註射器。同樣在 2022 年 10 月，生物製藥行業注射給藥技術的創新者 Credence Medsystems 獲得了Bill & Melinda Gates Foundation的資助，用於 Credence 用於發展中國家的雙室設計。注射器。因此，這種發展有望在未來幾年為雙腔注射器灌裝機製造商創造機會。

技術系統和 RABS 的高成本預計將阻礙市場增長

隔離器和限制進入屏障系統 (RABS) 等新技術系統的高成本阻礙了雙腔注射器灌裝機市場的增長。限制訪問屏障系統 (RABS) 和隔離器通常配備先進的功能，與傳統系統相比，這些功能提高了價格。隔離器和 RABS 的平均成本為 4-8 百萬美元，是傳統系統的 5 倍。這使得預算有限的小型製藥公司和研究機構很難購買此類設備。因此，在中國和印度等欠發達國家和發展中國家，目前隔離器和RABS的引入與傳統系統相比非常低。

行業分析

全球雙室注射器灌裝機市場基於各種行業因素，如波特五力、監管分析、供應鏈分析、定價分析、技術趨勢和進步、未滿足的需求、COVID-19 的影響等。提供詳細分析。

細分分析

自動化細分市場有望在全球雙腔注射器（DCS）灌裝機市場佔據最大市場份額

全球雙腔注射器灌裝機市場分為手動、半自動和自動。其中，預計自動化部分將在預測期內佔據雙腔注射器 (DCS) 灌裝機市場的最大份額。大型生產商對自動灌裝機的需求不斷增加，導致這一領域的增長。自動灌裝機的人工參與較少，因此藥物污染的可能性較小，因此被廣泛採用。自動灌裝機主要用於非處方藥。

根據應用，市場分為醫院藥房、工業藥房等。工業藥房在 2022 年將主導雙腔注射器灌裝機市場，因為它們涉及藥品的高生產、研究、包裝、質量控制和銷售。雙室注射器有助於輸送兩種藥物，以促進其在凍乾可注射藥物產品中的使用。製藥行業一直希望採用患者可以自行給藥的便捷產品。傳統系統被小型製藥和生物製藥公司、研發實驗室和學術機構廣泛使用。

區域分析

北美在全球雙腔注射器 (DCS) 灌裝機市場中佔有最大的市場份額。

由於注射器灌裝機的技術發展，北美雙室注射器灌裝機在 2022 年佔據了最大的市場份額，慢性病的上升導致對預灌裝注射器的需求增加。根據乙型肝炎基金會的數據，每年有超過 80,000 名美國人感染乙型肝炎，據說大約有 200 萬美國人患有慢性感染。在該地區，大多數製造商都獲得了乙肝疫苗預裝注射器的許可。例如，Dynavax 是獲得 FDA 批准的預灌封注射器疫苗 HEPLISAV-B 的主要製藥公司之一。在美國，預充式註射器將在接種疫苗方面發揮重要作用，因為在預測期內對 COVID-19 疫苗的需求將增加。注射器灌裝機也取得了重大進展，推動了該地區的市場增長。例如，北卡羅來納州阿什維爾的 Mission Health 安裝了兩個 ARxIUM RIV 自動 IV 分配系統，以無菌方式將液體和凍乾產品填充 IV 注射器和袋子，以交付給 Mission Health 患者。我正在管理。其他開發包括優傲機器人 UR-3 機械臂，它執行注射器灌裝和處理、小瓶灌裝和處理、標記和驗證、跟蹤和跟蹤以及唯一設備識別 (UDI)。這種情況進一步推動了市場。

另一方面，由於新興國家的健康意識不斷提高，對注射器灌裝機的需求增加，以及增加醫療器械製造能力。然後估計。

競爭格局

由於少數主要參與者的存在，雙室注射器 (DCS) 灌裝機市場競爭相對激烈。為市場增長做出貢獻的主要參與者包括 DARA Pharmaceutical、Syntegon Technology、Prosys Servo Filling Systems、TurboFil Packaging Machines 等。2022年，Bosch將旗下子公司之一Bosch Packaging Technology出售給CVC Capital Partners，並將其更名為Syntegon Technology。該公司是製藥、生物製藥和精細化學品、醫療器械和診斷、食品和糖果等多個行業的領先產品製造商。

領先公司正在採取多種增長戰略，例如產品發布、收購和合作夥伴關係，這有助於雙腔注射器 (DCS) 灌裝機市場的全球增長。例如，2022 年 1 月，ProMach 產品品牌 NJM 在 Interphex 展位上推出了 Dara NFL/2-RDL 無菌灌裝和封口機，用於使用 RayDyLyo 瓶蓋的即用型小瓶。

值得關注的重點公司

Dara Pharma

概述 Dara Pharma 是生物技術、製藥和化妝品行業的領先技術設備供應商。我們生產各種產品，例如小瓶、灌裝機、滅菌器、旋蓋機和半固體製劑。成立於 1996 年，總部位於巴塞羅那。

產品介紹

NFL/2-DC：雙腔注射器灌裝機，可用於填充和封蓋藥筒、小瓶和雙腔注射器。

重大發展。2022 年 4 月，Dara Pharma 為藥筒、注射器和小瓶設計了一種通用的交鑰匙解決方案。

全球雙室注射器 (DCS) 灌裝機市場報告提供大約 45 多個市場數據表、40 多個數字，並由 180 頁組成。

目錄

第一章 調查方法和範圍

  • 調查方法
  • 調查目的和範圍

第二章市場定義和概述

第三章執行摘要

第四章市場動態

  • 市場影響因素
    • 促進者
      • 灌裝機的技術進步
      • 注射器製造商擴大投資
    • 抑製劑
      • 隔離器成本高
      • 限制進入屏障系統 (RABS)
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析
  • 技術趨勢和進展
  • 未滿足的需求
  • COVID-19 的影響

第 6 章 按類型

  • 手動的
  • 半自動
  • 自動的

第 7 章 按申請

  • 醫院藥房
  • 工業藥品
  • 其他

第8章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東/非洲

第 9 章 競爭格局

  • 競爭情景
  • 市場/份額分析
  • 併購分析

第十章公司簡介

  • Dara Pharmaceutical Packaging
    • 公司簡介
    • 產品組合和描述
    • 主要發展狀況
    • 財務概覽
  • Syntegon Technology
  • Dymax Corporation
  • TurboFil Packaging Machine
  • Prosys Servo Filling Systems
  • Wenzhou Zhonguan Packaging Machinery
  • Optima Machinery Corporation
  • Shanghai Packaging Machinery
  • Inno4Life
  • Ashby Cross

第 11 章雙室注射器 (DCS) 灌裝機的全球市場-DataM

簡介目錄
Product Code: DMMDP2580

Market Overview

Dual Chamber Syringe (DCS) Filling Machine Market size was valued US$ 326.7 million in 2021 and is estimated to reach US$ 508.1 million by 2029, growing at a CAGR of 7.9% during the forecast period (2022-2029).

A dual-chamber syringe (DCS) filling machine is a device used for filling double-chamber syringes. The DCS machines are designed for filling dual chamber prefilled syringes with a combination of drugs which can either be liquid or powder. These machines are majorly used by industrial pharmacy and hospital pharmacy.

Market Dynamics

The market growth is driven by various factors such as growing investments by syringe manufactures and increasing novel technological advancements and enhancement in adoption of newer technologies.

Increasing novel scientific and technological advancement and growing investments are expected to drive market growth.

The global dual-chamber syringe filling machine market growth is majorly driven by the increasing technological advancements in filling machines. The increasing adoption of the newer dual-chamber technologies over the traditional dual-chamber syringe enhances the reliability, usability, and performance of the products. The introduction of isolators and restricted access barrier systems (RABS) creates a sterile manufacturing environment that can effectively separate the human operators from the fill-finish process. Several major device manufacturers in fill-finish manufacturing are innovating new barrier isolation systems, that are integrated fill-finish machines that can carry out all stages of fill-finish processes. On the other hand, the traditional equipment used in fill-finish operations is of high cost and time-consuming, which makes the entire process complex and prone to contamination. The conventional stainless-steel systems in traditional filling machines require additional cleaning and sterilization (CIP/SIP), whereas a single-use system eliminates the complex steps of sterilization and considerably reduces the change-over-time by simplifying end-of-batch breakdown and decontamination operations. For instance, DARA Pharmaceutical Packaging has introduced a dual-chamber syringe filling machine. Hence, owing to these factors, several biopharmaceutical companies are adopting these machines in drug production facilities.

Besides, the growing biopharmaceutical industry and rising investments by prefilled syringe manufacturers are also expected to drive the growth of the market during the forecast period. For instance, Nipro Corporation invested USD 14 million in its German and Japanese plants to expand the production capacity of prefilled syringes. The company is also developing dual chamber prefilled syringes for treating patients with prostate cancer and breast cancer. Also, in October 2022, Credence MedSystems, an innovator in injectable drug delivery technology for the biopharmaceutical industry, was awarded a grant from the Bill & Melinda Gates Foundation to support the development of Credence's Dual Chamber Reconstitution Syringe tailored for use in developing nations. Hence, these types of development are expected to create opportunities for dual-chamber syringe filling machine manufacturers in the coming years.

High cost of technological systems and RABS are expected to hamper the growth of market

The high cost of the new technological systems such as isolators and Restricted Access Barrier System (RABS) is hampering the growth of the dual-chamber syringe filling machine market. Restricted Access Barrier System (RABS) and isolators are well-equipped with advanced features which increases its price as compared to traditional systems. On average, isolators and RABS costs between US$ 4 million to US$ 8.0 million, which is five times that of traditional systems. Due to this, the accessibility is highly blocked for small pharma companies and research institutes that have a low budget for purchasing such equipment. Hence, the adoption of isolators and RABS is very low as compared to traditional systems in underdeveloped or developing countries, including China and India.

Industry Analysis

The global dual chamber syringe filling machine market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis, pricing analysis, technological trends and advancements, unmet needs, COVID-19 impact.

Segment Analysis

Automatic segment is expected to hold the largest market share in global dual chamber syringe (DCS) filling machine market

The global dual-chamber syringe filling machines are segmented into manual, semi-automatic, and automatic. Among these, the automatic segment is expected to gain maximum share during the forecast period in a dual-chamber syringe (DCS) filling machine market. The increasing demand for automatic filling machines by large-scale production companies is leading to the growth of this segment. The automatic filling machines have lower human involvement, which decreases the chances of drug contamination, hence are highly adopted. The automatic filling machines are mostly used for commercial drugs.

Based on applications, the market is classified into hospital pharmacy, industrial pharmacy, and others. The industry pharmacy is dominating the dual-chamber syringe filling machine market in 2022, as it involves high production, research, packaging, quality control, and sales of pharmaceutical products. The dual-chamber syringe helps in the delivery of two drugs to ease the use it is provided with lyophilized injectable drug products. The pharmaceutical industry always prefers to adopt convenient products to patients for self-administration. Traditional systems are still widely used in small pharma and biopharma companies, R&D laboratories, and academic institutes.

Geographical Analysis

North America region holds the largest market share in the global dual chamber syringe (DCS) filling machine market

North American dual-chamber syringe filling machines held the largest market share in 2022, owing to technological developments in the syringe filling machines, a rising number of chronic diseases which leads to more demand for prefilled syringes. According to the hepatitis B foundation, more than 80,000 Americans are infected with Hepatitis B annually, and around 2 million Americans are chronically infected. Most of the manufacturers are getting approval for prefilled syringes for Hepatitis B vaccines in this region. For instance, Dynavax was one of the major pharma companies to receive FDA approval for their prefilled syringe vaccine HEPLISAV-B. The prefilled syringes play an important role in the administration of the vaccine in the US as there is a rising demand for the COVID-19 vaccine over the forecast period. There have seen significant developments in the syringe filling machines which also drives the growth of the market in this region. For instance, NC-based Mission Health in Asheville installed two RIV automated IV compounding systems from ARxIUM that sterile-fill liquids and lyophilized products into IV syringes, and bags for administration to Mission Health patients. Also, there are developments, such as a Universal Robots UR-3 robotic arm to provide syringe filling and handling, vial filling and handling, mark and verify, track-and-trace, unique device identification (UDI) which further boosts the growth of the market.

On the other hand, the Asia-Pacific dual-chamber syringe (DCS) filling machine market is estimated to grow at the highest CAGR during the forecast period, owing to increased health awareness in developing countries, growing demand for syringe filling machines, and significant medical device manufacturing capacity.

Competitive Landscape

The Dual Chamber Syringe (DCS) Filling Machine market is moderately competitive with a few major players. Some of the key players which are contributing to the growth of the market are DARA Pharmaceutical, Syntegon Technology, Prosys Servo Filling Systems, TurboFil Packaging Machines, among others. In 2022, Bosch sold one of its subsidiaries, Bosch Packaging Technology, to CVC Capital Partners and was renamed Syntegon Technology. The company is a leading manufacturer of the product in several industries such as pharma, biopharma & fine chemicals, medical devices & diagnostics, food & confectionery, and other industries.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Dual Chamber Syringe (DCS) Filling Machine market globally. For instance, in January 2022, NJM, a ProMach product brand, introduced the Dara NFL/2-RDL aseptic filling and closing machine for ready-to-use vials utilizing the RayDyLyo cap at the Interphex booth.

Key Companies to Watch

Dara Pharmaceutical Equipment:

Overview: Dara Pharma is a company that provides advanced technological equipment to biotech, pharma and cosmetic industries. It manufactures variety of products such as vials, filling, sterilizing and closing machines, semi-solid products. It was founded in 1996 and is headquartered in Barcelona.

Product Portfolio:

NFL/2-DC: It is a dual chamber syringe filling machine that can be used for filling and closing of cartridges, vials and double chamber syringes.

Key Developments: In Apr 2022, Dara pharma designed a versatile turn key solutions for cartridges, syringes and vials.

The global dual chamber syringe (DCS) filling machine market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Technological advancements in filling machine
      • 4.1.1.2. Growing investments by syringe manufacturers
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of Isolators
      • 4.1.2.2. Restricted Access Barrier System (RABS)
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Regulatory Analysis
  • 5.3 Supply Chain Analysis
  • 5.4 Pricing Analysis
  • 5.5 Technological trends and advancements
  • 5.6 Unmet Needs
  • 5.7 COVID-19 Impact

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 6.1.2. Market Attractiveness Index, By Type Segment
  • 6.2. Manual
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Semi-automatic
  • 6.4. Automatic

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Hospital Pharmacy
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Industrial Pharmacy
  • 7.4. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. The U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. The U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. The Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. Dara Pharmaceutical Packaging
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Developments
    • 10.1.4. Financial Overview
  • 10.2. Syntegon Technology
  • 10.3. Dymax Corporation
  • 10.4. TurboFil Packaging Machine
  • 10.5. Prosys Servo Filling Systems
  • 10.6. Wenzhou Zhonguan Packaging Machinery
  • 10.7. Optima Machinery Corporation
  • 10.8. Shanghai Packaging Machinery
  • 10.9. Inno4Life
  • 10.10. Ashby Cross

LIST NOT EXHAUSTIVE

11. Global Dual Chamber Syringe (DCS) Filling Machine Market - DataM

  • 11.1. Appendix
  • 11.2. About Us and Method of Fixation
  • 11.3. Contact Us